Valeritas Holdings, Inc. (NASDAQ:VLRX) Investor Investigation over Potential Wrongdoing

An investigation on behalf of investors in Valeritas Holdings, Inc. (NASDAQ:VLRX) shares over potential wrongdoing at Valeritas Holdings was announced and NASDAQ:VLRX stockholders should contact the Shareholders Foundation.

Logo

San Diego, CA -- (SBWire) -- 06/09/2017 --An investigation on behalf of investors in shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) was announced over potential breaches of fiduciary duties by certain officers and directors at Valeritas Holdings.

Investors who purchased shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Valeritas Holdings officers and directors breached their fiduciary duties.

Valeritas Holdings, Inc.is a commercial-stage medical technology company that is focused on developing technologies for Type 2 diabetes. Shares of Valeritas Holdings, Inc. (NASDAQ:VLRX) declined from $7.29 per share in April 2017 to $4.53 per share on June 5, 2017

Those who purchased shares of Valeritas Holdings, Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

Media Relations Contact

Michael Daniels
General Manager
Shareholders Foundation
858-779-1554
http://www.ShareholdersFoundation.com

View this press release online at: http://rwire.com/818210